Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Townsquare Media (NYSE:TSQ) Posts Q3 Revenue Decline, Announces $0.20 Dividend

Townsquare Media, Inc. (NYSE:TSQ) released its financial results for the third quarter ended September 30, 2025. The company’s Board of Directors also approved a quarterly cash dividend of USD 0.20 per share, payable on February 2, 2026, to shareholders of record as of January …

Team Kalkine | 11 November 2025

QIAGEN (NYSE:QGEN) Unveils QIAsymphony Connect at AMP 2025 in Boston

QIAGEN N.V. (NYSE:QGEN; Frankfurt Prime Standard: QIA) announced the launch ofQIAsymphony Connect, the next generation of its automated nucleic acid purification platform, at the2025 Association for Molecular Pathology (AMP) Annual Meetingin Boston.

Team Kalkine | 11 November 2025

Analysts Maintain “Hold” Consensus on Endava Plc (NYSE:DAVA) Amid Mixed Ratings

Endava PLC Sponsored ADR (NYSE:DAVA) has received a consensus rating of “Hold” from ten analysts, according to Marketbeat data. Among them, one analyst rated the stock as “Sell”, six as “Hold”, and three as “Buy”. The average 12-month price target across these reports stands …

Aditi Sarkar | 10 November 2025

U.S. Markets Rebound as Shutdown Deal Nears and Rate Cut Hopes Lift Sentiment

Market Movers:On Friday, the top gainers were Motorsport Games Inc. (+70.78%), followed by Gulf Island Fabrication, Inc. (+49.68%). On the contrary Eledon Pharmaceuticals, Inc. (-49.76%), and Aimei Health Technology Co., Ltd (-42.66%) declined the most the same day.

Team Kalkine | 10 November 2025

Visionary Holdings (NASDAQ:GV) Launches Stem Cell Anti-Aging Line Across Asia

Visionary Holdings Inc., a technology-driven multinational enterprise listed on Nasdaq (NASDAQ:GV), announced that its wholly owned subsidiary,Visionary Health Technology Group Limited, has officially launched its medical-grade stem cell anti-aging product line. The initial rollout will focus on theChinese mainland and broader Asian markets.

Team Kalkine | 10 November 2025

ECD Automotive (NASDAQ:ECDA) Forms U.S. Alliance for New Luxury Defender and Grenadier Builds

ECD Automotive Design, Inc. (NASDAQ:ECDA), announced a U.S. distribution alliance with Chelsea Truck Company (“CTC”), a subsidiary of Kahn Design. The partnership will develop a new series of Land Rover Defender L663 and INEOS Grenadier builds under the joint brandECD × CTC.

Team Kalkine | 10 November 2025

WISeSat.Space Holdings to Go Public via WISeKey (NASDAQ:WKEY) and Columbus (NASDAQ:COLA) Deal

WISeKey International Holding AG (NASDAQ:WKEY)and Columbus Acquisition Corp. (NASDAQ:COLA), a publicly traded SPAC, have signed a definitive Business Combination Agreement. The agreement merges Columbus with WISeKey’s wholly owned subsidiary, WISeSat.Space Corp., resulting in a publicly listed entity on Nasdaq under the name WISeSat.Space Holdings …

Team Kalkine | 10 November 2025

Rumble (NASDAQ:RUM) Secures USD 150Mn GPU Commitment from Tether for AI

Rumble Inc. (NASDAQ:RUM)disclosed a significant GPU services commitment from Tether, the largest digital asset company and creator of the widely adopted dollar stablecoin. Tether’s initial pledge covers up to USD 150 mn of GPU services over a two-year period, dependent on the closing of …

Team Kalkine | 10 November 2025

Jabil (NYSE:JBL) and Inno to Co-Invest in New Battery Enclosure Manufacturing Site in Rayong

Jabil Inc. (NYSE:JBL), a global engineering, supply chain, and manufacturing solutions company, has announced an expanded collaboration with Inno, a metal parts manufacturer and subsidiary of Shanghai Xinpeng Industry Co. (XP). The two companies will jointly invest in a 15,000-square-meter, two-building facility in Rayong, …

Team Kalkine | 10 November 2025

Innate Pharma (Nasdaq: IPHA) Receives FDA Clearance to Initiate Phase 3 TELLOMAK 3 Trial

Innate Pharma SA (NASDAQ:IPHA) announced that the U.S. Food and Drug Administration (FDA) has completed its review of the confirmatory Phase 3 protocol for lacutamab in cutaneous T-cell lymphomas (CTCL). The FDA had no further comments, allowing the trial to proceed.

Team Kalkine | 10 November 2025
Support

Hi! How can we help you today?

Loading…